Phase 1 Heart Failure With Preserved Ejection Fraction (HFpEF) Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure With Preserved Ejection Fraction (HFpEF)Heart
Vasa Therapeutics42 enrolled21 locationsNCT07219511
Recruiting
Phase 1
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure With Preserved Ejection Fraction (HFpEF)
Secretome Therapeutics12 enrolled2 locationsNCT06560762